Joshua Berman, MD, PhD

Article

Recommending esketamine? 4 factors to consider

Author:: Joshua Berman, MD, PhD

Publish date: July 1, 2021

Since receiving FDA approval in March 2019, intranasal esketamine— the S-enantiomer of ketamine—has become a valuable treatment option for adults w...